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Abstract
Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. The
concept of individual microorganisms influencing the makeup of T cell subsets via interactions with intestinal dendritic cells
(DCs) appears to constitute the foundation for immunoregulatory effects of probiotics, and several studies have reported
probiotic strains resulting in reduction of intestinal inflammation through modulation of DC function. Consequent to a
focus on Saccharomyces boulardii as the fundamental probiotic yeast, very little is known about hundreds of non-
Saccharomyces yeasts in terms of their interaction with the human gastrointestinal immune system. The aim of the present
study was to evaluate 170 yeast strains representing 75 diverse species for modulation of inflammatory cytokine secretion
by human DCs in vitro, as compared to cytokine responses induced by a S. boulardii reference strain with probiotic
properties documented in clinical trials. Furthermore, we investigated whether cytokine inducing interactions between
yeasts and human DCs are dependent upon yeast viability or rather a product of membrane interactions regardless of yeast
metabolic function. We demonstrate high diversity in yeast induced cytokine profiles and employ multivariate data analysis
to reveal distinct clustering of yeasts inducing similar cytokine profiles in DCs, highlighting clear species distinction within
specific yeast genera. The observed differences in induced DC cytokine profiles add to the currently very limited knowledge
of the cross-talk between yeasts and human immune cells and provide a foundation for selecting yeast strains for further
characterization and development toward potentially novel yeast probiotics. Additionally, we present data to support a
hypothesis that the interaction between yeasts and human DCs does not solely depend on yeast viability, a concept which
may suggest a need for further classifications beyond the current definition of a probiotic.
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Introduction
The mucosal-associated lymphoid tissues lining the human
gastrointestinal tract contain a network of immune cells with the
important task of distinguishing potentially dangerous antigens
from harmless substances. Dendritic cells (DCs) govern the
balance between immunity and tolerance by sampling of intestinal
contents and initiating appropriate immune responses to luminal
antigens through pattern recognition receptor signaling, cytokine
secretion, and their ability to migrate and present antigen to naı¨ve
T cells in draining lymph nodes [1,2]. At homeostasis, DCs in the
intestinal mucosa are conditioned by commensal microorganisms
to promote proliferation of Foxp3+ regulatory T cells (Tregs), strong
producers of anti-inflammatory IL-10 contributing to intestinal
tolerance [1,3,4]. During infection or active inflammation,
pathogenic microorganisms bind to pattern recognition receptors
expressed by DCs and activate signaling pathways involving MAP
kinases and the nuclear transcription factor NFkB resulting in
production and secretion of a wide range of chemokines and
cytokines with distinct inflammatory effects. In this context, DC
secretion of inflammatory cytokines such as TNFa and IL-1b is
central for acute, innate inflammatory responses involving
attraction of neutrophils and macrophages to the site of infection.
In addition, DCs are central players in the regulation of adaptive
immune responses. For example, DC secretion of IL-12 and IL-6
promotes the proliferation of Th1 and Th17 subpopulations,
respectively, whereas DC modulation toward an IL-10 secreting
phenotype contributes to induction of Treg responses promoting
intestinal tolerance [5,6]. Furthermore, efficient antigen presenta-
tion relies upon DC maturation, a process involving upregulation
of co-stimulatory surface molecules as well as modulation of
chemokine receptor expression.
Probiotics are live microorganisms which when administered in
adequate amounts confer a health benefit on the host [7]. Based
on their role as key regulators of intestinal inflammation, DC
involvement in probiotic functionality has been studied extensively
[8–11]. The concept of individual commensal microorganisms
influencing the makeup of intestinal T cell subsets via interactions
with DCs appears to constitute the foundation for immunoregu-
latory effects of probiotics [4], and several studies have reported
probiotic strains resulting in reduction of intestinal inflammation
through modulation of DC function [8,9,12–14]. Consequently,
modulation of DC cytokine secretion and maturation by various
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microorganisms has elucidated species and strain specific effects
that have guided the selection of novel probiotic strains for further
investigation [15–17].
Although the gut microbiota is dominated by bacteria [18],
communities of eukaryotic microorganisms are part of the human
microbiome [19–21]. In addition, eukaryotes such as food-related
yeasts have been utilized for the production of fermented food and
beverages and consumed by humans for centuries [22]. Thus,
much like for prokaryotes, interactions between eukaryotic
microorganisms and the intestinal immune system may influence
human health in various ways. While the majority of probiotic
microorganisms studied to date are lactic acid producing bacteria,
research in yeasts with potentially beneficial influences on human
health has mainly revolved around Saccharomyces boulardii [23,24], a
yeast taxonomically acknowledged as belonging to the S. cerevisiae
species [25,26] but in the following text referred to as S. boulardii.
S. boulardii has been included in numerous randomized
controlled trials and strong clinical evidence exists for the use of
S. boulardii for the prevention of antibiotic associated diarrhea,
Traveler’s diarrhea, and acute infectious diarrheas [27,28]. In
addition, S. boulardii has shown a positive impact on disease
outcome in clinical studies of inflammatory bowel diseases such as
Crohn’s disease and ulcerative colitis [27], indicating an ability of
S. boulardii to influence human immune responses underlying
intestinal inflammation. The molecular basis for the beneficial
effects of S. boulardii has been subject to extensive study, in vitro as
well as in animal models, and S. boulardii has been found to impact
inflammatory cytokine production by intestinal epithelial cells [29–
34], peripheral blood mononuclear cells (PBMCs) [24], and DCs
[23,35–37], reducing inflammatory scores in experimental colitis
models in rodents [24,30,32,33,38–40].
Consequent to the intense research focus on S. boulardii as the
fundamental probiotic yeast, very little is known about hundreds of
non-Saccharomyces yeasts in terms of their interaction with the
human gastrointestinal immune system. Other food-related yeast
species typically associated with dairy products such as kefir and
traditional cheeses include Kluyveromyces lactis, Kluyveromyces marx-
ianus, and Debaryomyces hansenii [41]. While isolates of all three
species have been evaluated for potential probiotic properties in in
vitro experimental conditions assessing acid and bile survival, and
adhesion to and modulation of cytokine secretion from intestinal
epithelial cells [41–46], studies of the interactions between these
yeasts and specialized immune cells have been far fewer [47,48].
The current definition of probiotics as ‘‘live microorganisms
which when administered in adequate amounts confer a health
benefit on the host’’ places importance on the viability of probiotic
microorganisms at the site of action, presumably the lower small
intestines. This has led to numerous studies focusing on the ability
of potentially probiotic microorganisms to survive the harsh
conditions of the human gastrointestinal tract, i.e. the acidic
environment in the gastric sac and the presence of bile salts in the
proximal small intestines [41,42,47]. However, while probiotic
effects caused by actively secreted molecules will depend on a
probiotic microorganism being alive [23,30,34,35], other probiotic
effects may depend solely on the interaction of microbial cell wall
molecules and surface receptors expressed by host cells without the
need for an active metabolic function of the probiotic. Indeed,
several studies have found heat killed, UV irradiated, and live
bacteria to display equal DC stimulatory patterns in vitro [6,10,49–
52]. Others have described the failure of nonviable Saccharomyces
yeasts to prevent pathogen induced cytokine and chemokine
expression in cultured epithelial cells [29,43], while a third study
reported that S. boulardii maintained an inhibitory effect on
Salmonella induced signaling pathways in epithelial cells even after
being subjected to a membrane disrupting glass bead treatment,
thus indicating the likely importance of yeast cell wall structures
for the observed inhibition [32].
Multiplexed immunoassays based on the principles of flow
cytometry allow for simultaneous determination of numerous
soluble proteins in very small sample volumes. The combination of
high throughput and impressive accuracy, sensitivity, and repro-
ducibility make these experimental techniques highly relevant for
screening purposes where rapid quantification of multiple com-
pounds is critical [53,54].
The aim of the present study was to evaluate a broad spectrum
of yeasts (170 strains representing 75 diverse yeast species were
included in the study) for modulation of inflammatory cytokine
secretion by human DCs, as compared to cytokine responses
induced by a S. boulardii (Ultra-Levure) reference strain with
probiotic properties documented in clinical trials [27]. To our
knowledge, this is the first large-scale study of highly diverse yeasts
in terms of their modulation of DC function, incorporating
secretion levels of several cytokines. Furthermore, we investigated
whether cytokine inducing interactions between yeasts and human
DCs are dependent upon yeast viability or rather a product of
membrane interactions regardless of yeast metabolic function.
Materials and Methods
Yeast strains and growth conditions
Yeast strains included in this study were obtained from CBS
(www.cbs.knaw.nl). 170 strains were selected based on a desire to
include a broad range of yeast biodiversity (see complete list of
included strains in Table 1). Strains were cultured in YPD media
(0,5 % yeast extract, 1 % peptone, 1,1 % D-glucose) at 30uC under
aerobic conditions. Early stationary growth phase yeast cultures
were harvested by centrifugation, washed twice with DC media
(RPMI 1640 supplemented with 10 mM HEPES (Sigma-Aldrich,
Schnelldorf, Germany) and 50 mM 2-mercaptoethanol (Sigma-
Aldrich, Schnelldorf, Germany)), OD adjusted in DC media
containing 10 % glycerol, and cryopreserved at 280uC until time
of DC stimulation. Viability of frozen yeast cultures was verified by
staining with propidium iodide. For some experiments, yeast
strains were UV irradiated (70,000 mJ/cm2 for 5 min) or heat
treated (80uC at 650 rpm for 5 min) prior to cryopreservation at
280uC. Yeast cell viability after UV irradiation or heat treatment
was assessed by propidium iodide staining (UV ,40% intact cells;
heat ,20% intact cells), and the reproductive ability of UV
irradiated and heat treated yeasts was determined by colony
counts after 48 h incubation of YPD agar plates at 30uC.
Monocyte-derived DC generation
Immature monocyte-derived DCs were generated in vitro by a 6
day procedure as described [50]. Human buffy coats from healthy
donors were supplied by Department of Clinical Immunology at
Copenhagen University Hospital, Copenhagen, Denmark. Use of
human samples with no identifying information was approved by
The National Committee on Health Research and the Danish
Society for Clinical Immunology, and all donors gave informed
written consent upon donation. Briefly, human peripheral blood
mononuclear cells were obtained from buffy coats by density
gradient centrifugation using Ficoll-Paque PLUS (GE Healthcare,
Freiburg, Germany). Monocytes were isolated by positive selection
for CD14 using magnetic-activated cell sorting with CD14
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and
cultured at a density of 26106 cells/mL in complete DC media
(RPMI 1640 supplemented with 10 mM HEPES (Sigma-Aldrich,
Schnelldorf, Germany), 50 mM 2-mercaptoethanol (Sigma-Al-
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Table 1. Yeast strains included in study.
Genus Species Strains
Ambrosiozyma monospora CBS2554
Barnettozyma pratensis CBS9053, CBS9055
Bensingtonia yamatoana CBS9336
Botryozyma mucatilis CBS9042, CBS9043
Brettanomyces custersianus CBS4806, CBS5207, CBS5208
naardenensis CBS7540
Candida amphixiae CBS9877
anneliseae CBS9837
atakaporum CBS9833
athensensis CBS9840, CBS9841
blattae CBS9871
bohiensis CBS9897
bolitotheri CBS9832
bombi CBS9017
buenavistaensis CBS9895
choctaworum CBS9831
chrysomelidarum CBS9904
elateridarum CBS9842
ghanaensis CBS8798
gigantensis CBS9896
litsaeae CBS8799
michaelii CBS9878
palmioleophila CBS8109
powellii CBS8795
taliae CBS9838
Citeromyces siamensis CBS9152, CBS9153
Cryptococcus laurentii var. laurentii CBS8796
podzolicus CBS9357, CBS9358
Cryptotrichosporon anacardii CBS9549, CBS9551
Debaryomyces fabryi CBS10579
hansenii CBS116, CBS767, CBS773, CBS1101, CBS1119, CBS1121, CBS1123, CBS1129, CBS1519,
CBS1791, CBS1795, CBS1962, CBS2331, CBS2333, CBS4890, CBS5139, CBS5140, CBS6089,
CBS6574, CBS7032, CBS7848, CBS8339, CBS9682, CBS9685, CBS9696
subglobosus CBS792, CBS1128
Dekkera anomala CBS77, CBS4212, CBS4711, CBS7250, CBS8138
bruxellensis CBS72, CBS75, CBS96, CBS2547, CBS4459, CBS4482, CBS4601, CBS4602, CBS6055
Geotrichum cucujoidarum CBS9893
Hanseniaspora lachancei CBS8818, CBS8819
opuntiae CBS8820, CBS9791
Kazachstania exigua CBS9330
Kluyveromyces lactis var. drosophilarum CBS9056
lactis var. lactis CBS9057, CBS9058, CBS9059, CBS9060
marxianus CBS1553
Kurtzmaniella cleridarum CBS8793
Lachancea fermentati CBS797
kluyveri CBS6545, CBS6546, CBS6547
thermotolerans CHCC5756
Lodderomyces elongisporus CBS7803
Metschnikowia arizonensis CBS9064
borealis CBS8431, CBS8432
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drich, Schnelldorf, Germany), 2 mM L-glutamine (Life Technol-
ogies Ltd, Paisley, UK), 10 % heat-inactivated fetal bovine serum
(Invitrogen, Paisley, UK), 100 U/mL penicillin (Biological Indus-
tries, Kibbutz Beit-Haemek, Israel), and 100 mg/mL streptomycin
(Biological Industries, Kibbutz Beit-Haemek, Israel)) containing
30 ng/mL human recombinant IL-4 and 20 ng/mL human
recombinant GM-CSF (both from Sigma-Aldrich, Saint Louis,
USA) at 37uC, 5 % CO2. Fresh complete DC media containing
full doses of IL-4 and GM-CSF was added after three days of
culture. At day 6, differentiation to immature DCs was verified by
surface marker expression analysis (CD11c .90% expression;
CD1a .75% expression).
DC stimulation
Immature DCs were resuspended in fresh complete DC media
containing no antibiotics, seeded in 96-well plates at 16105 cells/
well, and allowed to acclimate at 37uC, 5 % CO2, for at least one
hour before stimulation. DC stimulation using thawed yeast strains
was performed at a yeast:DC ratio of 10:1, and stimulated DCs
were incubated for 20 h at 37uC, 5 % CO2, as time-course
experiments had shown a 20 h stimulation time to result in
quantifiable levels of all cytokines of interest. After 20 h
stimulation, DC supernatants were sterile filtered through a
0.2 mm AcroPrep Advance 96-well filter plate (Pall Corporation,
Ann Arbor, MI, USA) and stored at 280uC until time of cytokine
quantification.
DC staining for quantification of co-stimulatory
molecules and chemokine receptors
Immediately following 20 h stimulation time, DCs were
collected, centrifuged at 200x g for 5 min, and resuspended in
cold PBS containing 2 % BSA. Staining was performed using the
following monoclonal antibodies: FITC-conjugated anti-human
CD80 (clone L307.4), FITC-conjugated anti-human CD86 (clone
2331), APC-conjugated anti-human CCR6 (clone 11A9), FITC-
conjugated anti-human CCR7 (clone 150503), and appropriate
isotype controls (all from BD Biosciences, Erembodegem,
Belgium). DCs were incubated with mAb for 30 min on ice
protected from light, followed by repeated wash steps using 1 mL
cold PBS 2 % BSA. Finally, DCs were resuspended in PBS 2 %
BSA and kept on ice until flow cytometric analysis. Samples were
acquired on an LSRFortessa flow cytometer (BD Biosciences, San
Jose, CA, USA) using FACSDiva software (BD Biosciences, San
Jose, CA, USA).
Table 1. Cont.
Genus Species Strains
gruessii CBS9029, CBS9030
koreensis CBS9066
kunwiensis CBS9067, CBS9677, CBS9679, CBS9681
noctiluminum CBS9907
reukaufii CBS9018, CBS9019, CBS9020, CBS9021, CBS9022
Naumovozyma castelli CBS2248, CBS4310, CBS4906
dairensis CBS421
Ogataea dorogensis CBS9260, CBS9261
Pichia kluyveri CHCC11259
mandshurica CBS209
myanmarensis CBS9786
sporocuriosa CBS9200
Rhodosporidium diobovatum CBS9081, CBS9084
sphaerocarpum CBS9080
toruloides CBS14
Rhodotorula mucilaginosa var. mucilaginosa CBS9070, CBS9078, CBS9083
Saccharomyces arboricolus CBS10644
bayanus CBS381, CBS1641, CBS9787
boulardii CHCC11905, CHCC11906, 259*, 7103*, 7135*, 7136*, LSB*, Sb.A*, Sb.L*, Sb.P*
cariocanus CBS5313, CBS7994, CBS8841
cerevisiae CBS1646, CHCCJ4848, CBS6128, CHCC7036, CBS9564
kudriavzevii CBS8840
mikatae CBS8839, CBS10522, CBS10523
paradoxus CBS8442
pastorianus CBS1462, CBS1642
Zygosaccharomyces mellis CBS711, CBS738
rouxii CBS708, CBS733
Strain sources: CBS Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands
CHCC Chr. Hansen Culture Collection, Hørsholm, Denmark
* van der Aa Ku¨hle, A., Jespersen, L., 2003. Systematic and Applied Microbiology 26, 564–571.
doi:10.1371/journal.pone.0096595.t001
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Cytokine quantification
Secreted levels of IL-12, TNF, IL-10, IL-6, and IL-1b were
quantified by the Human Inflammatory Cytokines cytometric
bead array (CBA) kit (BD Biosciences, Erembodegem, Belgium)
according to the manufacturer’s instructions. Briefly, fluorescent
beads coated with monoclonal capture antibodies were mixed with
PE conjugated detection antibodies and recombinant standards or
test samples and allowed to form sandwich complexes during 3 h
incubation protected from light. After repeated wash steps,
samples were acquired on an LSRFortessa flow cytometer (BD
Biosciences, San Jose, CA, USA) and data analysis was performed
using the FCAP Array 3 software (BD Biosciences, San Jose, CA,
USA). Detection limits for individual cytokines were as follows:
1.9 pg/mL IL-12, 3.7 pg/mL TNF, 3.3 pg/mL IL-10, 2.5 pg/
mL IL-6, and 7.2 pg/mL IL-1b.
Multivariate data analysis and statistical analysis
Multivariate data analysis was performed using SIMCA-P+ 13
(Umetrics, Umea˚, Sweden). A PCA-class model was generated
based on data for induced levels of IL-12, IL-10, IL-6, TNFa, and
IL-1b by 12 biological replicates of the S. boulardii reference strain,
thereby centering the plot point of origin on the cytokine profile
induced by the S. boulardii reference strain. Induced cytokine data
(IL-12, IL-10, IL-6, TNFa, and IL-1b) for the 170 yeast strains
included in the screen constituted the prediction data set; i.e. the
distance of a given yeast strain from the plot point of origin
indicates how closely the induced cytokine profile resembles that of
the S. boulardii reference strain.
Statistical analysis (one-way ANOVA with Bonferroni’s multiple
comparison post test) was performed using GraphPad Prism 5
(GraphPad Software, La Jolla, USA).
Results
Yeasts induce highly diverse cytokine profiles in human
DCs
Given that modulation of DC cytokine secretion has been linked
to probiotic functionality related to intestinal inflammation, we
evaluated yeast modulation of DC secretion of five inflammation
related cytokines in vitro. We exposed human DCs to each yeast
strain in duplicate at a 10:1 yeast:DC ratio and quantified secreted
levels of IL-12, IL-10, IL-6, TNFa, and IL-1b after 20 h
stimulation. Stimulation time was selected based on time-course
experiments indicating 20 h as ideal for obtaining quantifiable
levels of cytokines produced at a slow rate (IL-12, IL-10, and IL-
1b) without reaching saturation conditions for rapidly secreted
cytokines (IL-6 and TNFa) (Fig S1). As a point of reference, we
included a S. boulardii strain with probiotic effects documented in
clinical trials [27]. As expected, S. boulardii engaged human
immune cells, as evidenced by induction of a robust response
across all five cytokines (Fig 1). In addition, S. boulardii induced
high levels of the co-stimulatory molecules CD80 and CD86,
indicative of strong activation of the immature DCs (Fig S2), and
affected DC chemokine receptor expression, as observed by down-
regulation of CCR6 and strong up-regulation of CCR7 (Fig S2),
indicating that S. boulardii activates immature DCs to a mature
phenotype primed for lymph node migration and efficient antigen
presentation.
For comparison of the yeast induced DC cytokine profiles,
multivariate data analysis was applied as a valuable tool for
visualizing and grouping yeast strains based on quantified levels of
all five cytokines. A PCA-class model was generated based on data
for induced levels of IL-12, IL-10, IL-6, TNFa, and IL-1b by 12
biological replicates of the S. boulardii reference strain, thereby
centering the PCA plot point of origin on the cytokine profile
induced by the reference strain (Fig 2). Induced cytokine data (IL-
12, IL-10, IL-6, TNFa, and IL-1b) for the 170 yeast strains
included in the study constituted the prediction data set; i.e. the
distance of a yeast strain from the plot point of origin indicates
how closely the induced cytokine profile resembles that of the S.
boulardii reference strain. Visualizing the obtained cytokine profiles
in this way revealed the interesting fact that induction of all five
cytokines was positively correlated in our study, as shown by the
loadings of individual cytokines in the Figure 2 insert.
As displayed in Figure 2, the yeasts included in this study
induced highly diverse cytokine profiles in human DCs. Not
surprisingly, the majority of Saccharomyces yeasts induced cytokine
profiles very similar to the S. boulardii reference strain, as indicated
by their location very close to the plot point of origin in Figure 2.
In addition, this overview plot shows Saccharomyces yeasts as strong
cytokine inducers, with very few non-Saccharomyces yeasts inducing
cytokine levels higher than the S. boulardii reference strain (i.e. not
many yeast strains present in the upper right quadrant of the plot).
For non-Saccharomyces yeasts, we observe a broad range of cytokine
inducing properties. For instance, a third of the included
Debaryomyces strains, several Dekkera strains, and all included
Zygosaccharomyces isolates dominate a distinct cluster of very low
cytokine inducing yeasts present at the bottom left corner of the
plot (Fig 2).
Distinct differences observed in cytokine inducing
properties of individual yeast genera
Next, we focused on the induced DC cytokine profiles of
individual yeast genera. Six Kluyveromyces strains representing the
species K. marxianus, K. lactis var. lactis, and K. lactis var. drosophilarum
were included in our study, and multivariate data analysis of the
induced DC cytokine profiles revealed clear species distinctions in
immune stimulating capacities (Fig 1A). K. marxianus (CBS1553)
induced DC cytokine levels statistically indistinguishable (P.0.05)
from the profile induced by the S. boulardii reference strain for
every one of the quantified cytokines (Fig 1B-F). In contrast, the
four K. lactis var. lactis strains (CBS9057, CBS9058, CBS9059,
CBS9060) induced much lower levels of cytokines; in particular,
induced levels of IL-12, IL-10, and IL-1b were near or below the
detection limit of the assay. Strikingly, no significant differences
were observed between the DC cytokine profiles induced by the
four K. lactis var. lactis strains (Fig 1B-F, P.0.05 for all quantified
cytokines).
For Debaryomyces yeasts, 25 of the 28 strains included in our study
represented the species D. hansenii, and the induced DC cytokine
profiles revealed a remarkable diversity in immune stimulating
properties (Fig 3A). The strain CBS1121 induced DC cytokine
levels similar to the S. boulardii reference strain (Fig 3B-F), as
indicated by secreted levels of IL-1b, IL-6, and TNFa being
statistically indistinguishable from S. boulardii induced levels. The
D. hansenii type strain (CBS767) displayed much poorer cytokine
induction capabilities, as seen by significantly lower induction of
the pro-inflammatory cytokines IL-12, IL-6, and TNFa. Finally,
the D. hansenii strain CBS7848 induced a DC cytokine profile
characterized by levels of IL-1b, IL-10, IL-6, and TNFa
significantly higher than the S. boulardii reference strain, yet failed
to induce detectable levels of IL-12.
The yeast genus Metschnikowia represents a large family of yeasts
which, to the best of our knowledge, has not been explored for
properties relating to human health. The PCA plot in Figure 4A
displays the DC cytokine profiles induced by the 16 isolates
representing seven Metschnikowia species included in our study. The
plot reveals striking species distinctions separating species with
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highly diverse cytokine inducing properties. While isolates of M.
reukaufii induced DC cytokine profiles very similar to the S. boulardii
reference strain across all five cytokines, M. gruessii isolates induced
robust levels of IL-1b, IL-10, IL-6, and TNFa, yet undetectable
levels of IL-12 (Fig 4B-F). In contrast, M. borealis displayed poor
cytokine inducing properties in general, as seen by an induced DC
cytokine profile characterized by significantly lower cytokine levels
compared to the S. boulardii reference strain.
Yeasts are capable of DC stimulation independently of
viability
Next, we investigated whether the observed interactions
between yeasts and DCs were dependent upon yeast viability.
We hypothesized that yeasts would be able to induce DC
activation regardless of metabolic activity and conducted exper-
iments to compare DC stimulation with live, UV irradiated, and
heat treated yeast. UV irradiation conditions were designed to
generate relatively intact yeast cells unable to reproduce, whereas
heat treatment was intended to cause severe yeast cell membrane
disruption. Propidium iodide staining confirmed a reduction in the
proportion of intact yeast cells to levels below 40% after UV
Figure 1. DC cytokine secretion induced by Kluyveromyces yeasts. A. Principal component analysis (PCA) scatter plot of DC cytokine profiles
induced by Kluyveromyces yeast strains and the S. boulardii reference strain. Each dot represents induced cytokine data (IL-12, IL-10, IL-6, TNFa, and IL-
1b) for one yeast strain, entered as the mean value of two biological replicates, and colored according to yeast species. The six red dots representing
biological replicates of the S. boulardii reference strain show the deviation in the model. The insert represents loadings of individual cytokines
included in the PCA model; for example, high IL-12 inducing yeasts are placed high along the plot Y axis, whereas strong IL-10 inducing yeasts are
located to the right along the plot X axis. Levels of B. IL-1b, C. IL-12, D. IL-10, E. IL-6, and F. TNFa secreted by human monocyte-derived DCs
following 20 h stimulation with DC media containing 10 % glycerol (unstimulated) or S. boulardii (Ultra-Levure), K. marxianus (CBS1553), or K. lactis
var. lactis (CBS9057, CBS9058, CBS9059, CBS9060) at a yeast:DC ratio of 10:1. Data are representative of two independent experiments, error bars
represent SEM. One-way ANOVA, Bonferroni’s multiple comparison post test, indicating significant differences from cytokine levels induced by S.
boulardii. ns, not significant; *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0096595.g001
Figure 2. Yeast induced cytokine profiles in human DCs. Principal component analysis (PCA) scatter plot of induced cytokine data for 170
yeast strains included in screen. Each dot represents induced cytokine data (IL-12, IL-10, IL-6, TNFa, and IL-1b) for one yeast strain, entered as the
mean value of two biological replicates, and colored according to yeast genera. The plot point of origin is centered on the cytokine profile induced by
the S. boulardii reference strain, and thus the distance of a given yeast strain from the plot point of origin indicates how closely the induced cytokine
profile resembles that of the S. boulardii reference strain. The insert represents loadings of individual cytokines included in the PCA model; for
example, high IL-12 inducing yeasts are placed high along the plot Y axis, whereas strong IL-10 inducing yeasts are located to the right along the plot
X axis.
doi:10.1371/journal.pone.0096595.g002
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irradiation and below 20% after heat treatment, and the
reproductive inability of UV irradiated and heat treated yeasts
was verified by colony counts (data not shown). As presented in
Figure 5, the obtained data show no significant differences in
cytokine inducing properties between live, UV irradiated, and heat
treated S. boulardii. Additionally, UV irradiated and heat treated S.
boulardii were as effective as live yeast in inducing DC co-
stimulatory functions and altering chemokine receptor expression
levels (Fig S2). Regardless of UV irradiation or heat treatment, S.
boulardii induced high levels of the co-stimulatory molecules CD80
and CD86, and modulated DC chemokine receptor expression, as
observed by down-regulation of CCR6 and strong up-regulation
of CCR7 (Fig S2).
For non-Saccharomyces yeasts, we observed a remarkably similar
pattern. K. marxianus induced DC secretion of IL-12, IL-10, IL-6,
TNFa, and IL-1b was unaffected by UV irradiation or heat
treatment of the yeast (Fig 5). In contrast, the ability of K. lactis var.
lactis (CBS9057) to induce IL-10 appeared slightly stronger after
heat treatment, whereas induced levels of IL-12, IL-6, TNFa, and
IL-1b remained unchanged. D. hansenii (CBS1121) induced
cytokine secretion was unaffected by UV irradiation as well as
heat treatment (Fig 5). For Metschnikowia yeasts, we observed
differential modification of cytokine inducing properties between
the three species examined. Whereas M. gruessii and M. borealis
were unaffected by UV irradiation as well as heat treatment, the
IL-10 inducing properties of M. reukaufii appeared slightly
potentiated by the heat treatment (Fig 5).
Discussion
The complex interplay between the gut microbiota and the
intestinal immune system as this relates to human health and
disease has received increasing attention recently [3,4,19]. Novel
understandings of how the composition of resident populations of
intestinal microorganisms can significantly impact human health
in areas as diverse as obesity, allergy, and inflammatory disorders,
is making this an area of intense research [19]. Maintenance of
intestinal homeostasis requires a carefully regulated network of
immune cells responsible for controlling the delicate balance
between populations of potentially pro-inflammatory effector cells
such as Th1 and Th17 cells and anti-inflammatory Treg cells [4],
and intestinal DCs play a central role in orchestrating both innate
and adaptive immune responses to commensal microorganisms as
well as invasive pathogens [1,10].
As research in yeasts with a potentially beneficial impact on
human health has focused almost exclusively on S. boulardii, the
aim of the present study was to evaluate immune modulation by a
large number of highly diverse yeasts in order to build a data set to
serve as a foundation for selecting strains for further mechanistic
studies. Choosing an experimental system involving human
monocyte-derived DCs resulted in the necessary throughput and
by employing a multiplexed immunoassay and multivariate data
analysis to incorporate data for yeast induced DC secretion of five
cytokines with distinct inflammatory effects we were able to assess
the modulation of DC cytokine secretion by 170 yeast strains
representing a broad spectrum of biodiversity. In contrast to
studies focusing on modulation of a challenge induced DC
cytokine response [23,36], our experimental setup evaluated the
ability of yeasts to engage DCs per se.
The ability of S. boulardii to engage human immune cells and
influence cytokine secretion in vitro is well established and has been
linked to improved inflammatory scores in rodent colitis models.
Likewise, commensal bacterial strains have been found to induce
strong DC maturation and inflammatory cytokine secretion, yet
display tolerogenic properties promoting T cell hyporesponsive-
ness [10], and strains with known probiotic properties have been
shown to induce transient pro-inflammatory host responses in
rodents upon initial colonization [55]. Accordingly, we observed
robust induction of DC cytokines when human DCs were cultured
in the presence of a S. boulardii reference strain with probiotic
properties documented in clinical trials [27], indicating the
expected ability of S. boulardii to engage human DCs and impact
their secretion of cytokines with distinct inflammatory effects. In
addition, we found the S. boulardii reference strain capable of
inducing co-stimulatory functions and modulating chemokine
receptor expression towards an activated DC phenotype primed
for lymph node migration and efficient antigen presentation.
These findings are supported by reports of S. boulardii modulating
LPS induced CD80 and CCR7 expression [23,35], and echo
reports of commensal bacterial strains inducing DC maturation, as
indicated by increased surface expression of CD80, CD86, and
CCR7 [8,10]. Our observation that yeasts belonging to the
Saccharomyces genus are among the strongest cytokine inducing
yeasts included in the present study, and that all included
Saccharomyces yeasts induce DC cytokine profiles very similar to
that induced by the S. boulardii reference strain, parallels the
finding of a recent study where six live yeast strains representing
the species S. bayanus, S. cerevisiae, and S. pastorianus induced non-
discriminatory cytokine profiles in human PBMCs [24].
The remarkable diversity in cytokine inducing properties
observed for non-Saccharomyces yeasts reflects the high diversity
among the included yeast isolates. As the selection criteria for
inclusion in the present study were based on a desire to include a
broad representation of yeast biodiversity and thus had no
apparent link to properties of immune modulation, it is not
surprising that while some non-Saccharomyces yeasts exhibit strong
cytokine inducing properties, others present as far more immuno-
logically inert.
It is generally accepted that probiotic properties of bacteria are
not only species but also strain dependent [56–58]. Interestingly,
whereas our data agree with this notion for a number of included
yeast species, other yeast genera display distinct species clustering
in DC cytokine inducing properties.
The genus Kluyveromyces includes food-related yeasts typically
isolated from fermented dairy products, and the health-promoting
effects associated with the consumption of these products have led
Figure 3. DC cytokine secretion induced by Debaryomyces yeasts. A. Principal component analysis (PCA) scatter plot of DC cytokine profiles
induced by Debaryomyces yeast strains and the S. boulardii reference strain. Each dot represents induced cytokine data (IL-12, IL-10, IL-6, TNFa, and IL-
1b) for one yeast strain, entered as the mean value of two biological replicates, and colored according to yeast species. The six red dots representing
biological replicates of the S. boulardii reference strain show the deviation in the model. The insert represents loadings of individual cytokines
included in the PCA model; for example, high IL-12 inducing yeasts are placed high along the plot Y axis, whereas strong IL-10 inducing yeasts are
located to the right along the plot X axis. Levels of B. IL-1b, C. IL-12, D. IL-10, E. IL-6, and F. TNFa secreted by human monocyte-derived DCs
following 20 h stimulation with DC media containing 10 % glycerol (unstimulated), S. boulardii (Ultra-Levure), or D. hansenii (CBS1121, CBS767,
CBS7848) at a yeast:DC ratio of 10:1. Data are representative of two independent experiments, error bars represent SEM. One-way ANOVA,
Bonferroni’s multiple comparison post test, indicating significant differences from cytokine levels induced by S. boulardii. ns, not significant; *, P,
0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0096595.g003
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to several studies investigating individual isolates for properties
related to human health. A recent study evaluating the immune
modulatory properties of a K. marxianus strain in vitro found a
significant impact on the cytokine secretion of IL-6, TNFa, and
IL-1b by human PBMCs [47]. While the K. marxianus isolate
included in the present study is not identical, this does support our
observation that K. marxianus induces a cytokine profile statistically
indistinguishable from that of the S. boulardii reference strain,
clearly indicating the ability of K. marxianus to engage specialized
immune cells and impact the secretion of cytokines with distinct
effects on adaptive immune responses. We observed distinct
species differences clearly separating K. marxianus and K. lactis var.
lactis in terms of their ability to induce DC cytokine secretion, with
all four K. lactis var. lactis strains displaying an apparent inability to
induce significant levels of cytokines. This is supported by a study
finding K. lactis unable to induce detectable levels of the cytokines
IL-6 and TNFa in a system evaluating interactions between yeast
and cultured intestinal epithelial cells [44]. As the same study
found K. lactis yeasts able to stimulate IL-8 secretion, our data may
reflect differences between yeasts mainly interacting with highly
abundant epithelial cells triggering innate immune mechanisms
such as neutrophil and monocyte recruitment and yeasts capable
of engaging specialized immune cells playing an active role in
adaptive immune responses.
As discussed above, the species distinction in DC cytokine
inducing properties is unmistakable for Kluyveromyces yeasts
included in the present study. In contrast, the included isolates
representing another genus comprising many food-related yeasts,
namely Debaryomyces, display highly diverse and strain dependent
DC inducing properties. Despite being highly abundant in nature
and well known as food-related yeasts typically isolated from dairy,
meat, and fermented soy products [59], all of which suggest likely
human contact with these microorganisms, Debaryomyces yeasts
have not been thoroughly studied for properties relating to human
health.
The aim of the present study was to provide a first step in a
search for novel yeasts with the ability to impact human health
through interactions with the intestinal immune system, and
naturally, safety constitutes an important factor when considering
novel microorganisms with the potential for development of
products aimed at human consumption. Consequently, focusing
further studies solely on yeast species approved by the European
Food Safety Authority for holding qualified presumption of safety
(QPS) becomes an attractive proposition. This would suggest an
emphasis on K. marxianus, K. lactis, and D. hansenii, all of which hold
QPS status [60] and, in the present study, displayed DC cytokine
induction properties worthy of further investigation. However,
limiting future efforts to already well-known food-related yeasts
would present the inherent risk of missing less-studied yeasts with
potentially superior properties. The yeast genus Metschnikowia,
comprising a large family of yeasts primarily isolated from flowers
and bees across the European continent, provides an example. To
the best of our knowledge, Metschnikowia yeasts have not been
subject to studies relating to human health, yet the numerous
isolates included in our study exhibited a remarkable species
distinction in DC cytokine inducing properties warranting further
examination.
While the experimental conditions in this study were intended
to simulate the in vivo situation where microorganisms encounter
mucosal DCs during passage through the human gut; naturally,
some limitations need to be kept in mind when interpreting the
data. Notably, single strain stimulation of DCs may be a necessity
for data analysis when evaluating numerous strains but it fails to
account for interactions between different members of the
intestinal flora. Given the complexity of the human microbiota,
the likely interactions between yeasts and other microorganisms
present in the intestinal tract may result in different DC cytokine
profiles. This highlights the importance of extending the current
knowledge of select strains through additional studies incorporat-
ing a more complex mix of microorganisms resembling that of the
human gastrointestinal tract.
From an industrial point of view, it is of importance to know
whether dead yeast cells can be used in the same manner as viable
cells. Additionally, yeast cells present in the human gastrointestinal
tract may be either viable or dead, which makes it relevant to
investigate whether the immunological responses are the same.
Further, as yeast cell wall composition and structure are known to
vary depending on yeast growth phase and any treatment, the
prospect that cell wall structures of nonviable yeast cells may differ
from those of viable yeast cells and in turn potentially trigger a
different immunological response, led us to explore whether DC
cytokine induction was affected by yeast viability. We observed no
significant differences between the DC cytokine inducing proper-
ties of live, UV irradiated, and heat treated S. boulardii, and in
addition, DC co-stimulatory functions were upregulated to an
equal extent by live and reproductively unable yeast.
The remarkable consistency in DC cytokine inducing properties
observed across very diverse yeast species and genera regardless of
viability appears to support our hypothesis that interactions
between yeasts and immune cells are likely to rely upon contact
between (possibly conserved) yeast cell wall structures and DC
surface receptors. Further, our findings suggest that this phenom-
enon holds true for a number of diverse yeast species beyond the
widely studied Saccharomyces genus. In this context, it is interesting
to note that a recent study have found yeast cell wall fractions, and
particularly b-glucan fractions, prepared from either S. cerevisiae or
C. albicans, able to modulate intestinal inflammation in vivo [40],
potentially through interactions with the C-type lectin receptor
Dectin-1 expressed by DCs [61,62]. Thus, while our findings for
nonviable yeasts beyond S. cerevisiae and C. albicans appear to
extend their observation that yeast cell wall molecules are capable
of interacting with immune cells, their findings support our
hypothesis that yeast modulation of intestinal inflammation can
take place without the need for live yeast cells.
In conclusion, the present study provides the first large-scale
study of immune modulation by highly diverse yeasts described in
Figure 4. DC cytokine secretion induced by Metschnikowia yeasts. A. Principal component analysis (PCA) scatter plot of DC cytokine profiles
induced byMetschnikowia yeast strains and the S. boulardii reference strain. Each dot represents induced cytokine data (IL-12, IL-10, IL-6, TNFa, and IL-
1b) for one yeast strain, entered as the mean value of two biological replicates, and colored according to yeast species. The six red dots representing
biological replicates of the S. boulardii reference strain show the deviation in the model. The insert represents loadings of individual cytokines
included in the PCA model; for example, high IL-12 inducing yeasts are placed high along the plot Y axis, whereas strong IL-10 inducing yeasts are
located to the right along the plot X axis. Levels of B. IL-1b, C. IL-12, D. IL-10, E. IL-6, and F. TNFa secreted by human monocyte-derived DCs
following 20 h stimulation with DC media containing 10 % glycerol (unstimulated) or S. boulardii (Ultra-Levure), M. reukaufii (CBS9018, CBS9019,
CBS9020, CBS9021, CBS9022), M. gruessii (CBS9029, CBS9030), or M. borealis (CBS8431, CBS8432) at a yeast:DC ratio of 10:1. Data are representative of
two independent experiments, error bars represent SEM. One-way ANOVA, Bonferroni’s multiple comparison post test, indicating significant
differences from cytokine levels induced by S. boulardii. ns, not significant; *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0096595.g004
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the scientific literature. Our data clearly demonstrate high
diversity in yeast induced cytokine secretion across a broad
spectrum of yeasts, and by employing multivariate data analysis we
reveal distinct clustering of yeasts inducing similar cytokine profiles
in DCs, highlighting clear species distinction within specific yeast
genera. The observed differences in induced DC cytokine profiles
may indicate distinct modes of interaction between yeasts and
human immune cells, and will aid in the selection of strains for
further characterization and development toward potentially novel
yeast probiotics. Additionally, we present data to support a
hypothesis that the interaction between yeasts and human DCs
does not solely depend on yeast viability, a concept which may
suggest a need for further classifications beyond the current
definition of a probiotic.
Supporting Information
Figure S1 Time-course of S. boulardii induced DC
cytokine secretion supports a 20 h stimulation time.
Levels of IL-12, IL-10, IL-1b, IL-6, and TNFa secreted by human
monocyte-derived DCs following incubation with S. boulardii
(Ultra-Levure) at a yeast:DC ratio of 10:1. Data are expressed as
mean6SEM (n= 2).
(TIF)
Figure S2 Modulation of DC co-stimulatory functions
and chemokine receptor expression occurs indepen-
dently of yeast metabolic function. DC surface expression of
CD80, CD86, CCR6, and CCR7 following 20 h stimulation with
DC media containing 10% glycerol (unstimulated) or either live,
UV irradiated, or heat killed S. boulardii (Ultra-Levure) at a
yeast:DC ratio of 10:1. Data are expressed as mean6SEM (n= 4).
One-way ANOVA, Bonferroni’s multiple comparison post test,
indicating significant differences between cytokine levels induced
by live, UV treated, and heat killed yeast. ns, not significant; *, P,
0.05; **, P,0.01; ***, P,0.001.
(TIF)
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